abstract |
The present invention relates to leptin proteins, mutant fragments or mimetics of leptin proteins, for the manufacture of a medicament that can be used to improve cognitive function or to treat undesirable signs of nutritional stress conditions and prolong survival. It relates to the use of activators of the AMPK signaling pathway. [Selection] Figure 4A |